These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 15956221)
1. Comment: Promethazine adverse events after implementation of a medication shortage interchange. Habib AS; Breen TW; Gan TJ Ann Pharmacother; 2005; 39(7-8):1370; author reply 1370-1. PubMed ID: 15956221 [No Abstract] [Full Text] [Related]
2. Promethazine adverse events after implementation of a medication shortage interchange. Sheth HS; Verrico MM; Skledar SJ; Towers AL Ann Pharmacother; 2005 Feb; 39(2):255-61. PubMed ID: 15644479 [TBL] [Abstract][Full Text] [Related]
3. Is Promethazine 6.25 mg Intravenous Dose Really Ideal to Treat Postoperative Nausea and Vomiting? Zhu LL; Chen M; Zhou Q J Perianesth Nurs; 2015 Aug; 30(4):269-71. PubMed ID: 26210556 [No Abstract] [Full Text] [Related]
4. Neuroleptic malignant syndrome with promethazine. Mendhekar DN; Andrade C Aust N Z J Psychiatry; 2005; 39(1-2):113-4. PubMed ID: 15660719 [No Abstract] [Full Text] [Related]
5. A comparison of ondansetron with promethazine for treating postoperative nausea and vomiting in patients who received prophylaxis with ondansetron: a retrospective database analysis. Habib AS; Reuveni J; Taguchi A; White WD; Gan TJ Anesth Analg; 2007 Mar; 104(3):548-51. PubMed ID: 17312206 [TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting. Gan TJ; Sinha AC; Kovac AL; Jones RK; Cohen SA; Battikha JP; Deutsch JS; Pergolizzi JV; ; Glass PS Anesth Analg; 2009 May; 108(5):1498-504. PubMed ID: 19372328 [TBL] [Abstract][Full Text] [Related]
7. No more than necessary: safety and efficacy of low-dose promethazine. Moser JD; Caldwell JB; Rhule FJ Ann Pharmacother; 2006 Jan; 40(1):45-8. PubMed ID: 16352779 [TBL] [Abstract][Full Text] [Related]
8. Two masters. Schneider CE Hastings Cent Rep; 2010; 40(1):9-10. PubMed ID: 20166509 [No Abstract] [Full Text] [Related]
9. [Prevention and treatment of postoperative nausea and vomiting in children. An evidence-based approach]. Tramèr MR Ann Fr Anesth Reanim; 2007 Jun; 26(6):529-34. PubMed ID: 17521856 [TBL] [Abstract][Full Text] [Related]
10. Comparison of metoclopramide, prochlorperazine and placebo in prevention of postoperative nausea and vomiting (PONV) following tonsillectomy in young adults. Jamil M; Gilani SM; Khan SA J Ayub Med Coll Abbottabad; 2005; 17(4):40-4. PubMed ID: 16599033 [TBL] [Abstract][Full Text] [Related]
11. Universal PONV prophylaxis in general anesthesia: should we consider its immediate implementation? Dürsteler C; Mases A; Puig MM Anesth Analg; 2008 Jun; 106(6):1922; author reply 1922-3. PubMed ID: 18499635 [No Abstract] [Full Text] [Related]
12. Preoperatively administered ramosetron oral disintegrating tablets for preventing nausea and vomiting associated with patient-controlled analgesia in breast cancer patients. Lee HJ; Kwon JY; Shin SW; Kim CH; Baek SH; Baik SW; Kim HK; Kim KH Eur J Anaesthesiol; 2008 Sep; 25(9):756-62. PubMed ID: 18426627 [TBL] [Abstract][Full Text] [Related]
15. Haloperidol vs. ondansetron for the prevention of postoperative nausea and vomiting following gynaecological surgery. Aouad MT; Siddik-Sayyid SM; Taha SK; Azar MS; Nasr VG; Hakki MA; Zoorob DG; Baraka AS Eur J Anaesthesiol; 2007 Feb; 24(2):171-8. PubMed ID: 16938159 [TBL] [Abstract][Full Text] [Related]
16. [Perineal pruritus after intravenous injection of dexamethasone for postoperative prophylaxis of nausea and vomiting]. Sánchez Ortega JL; Verdú Martínez MT; Burguillos López S Rev Esp Anestesiol Reanim; 2005; 52(6):376-7. PubMed ID: 16038183 [No Abstract] [Full Text] [Related]
18. Extravasation of i.v. promethazine. Malesker MA; Malone PM; Cingle CM; Cochran RM Am J Health Syst Pharm; 1999 Sep; 56(17):1742-3. PubMed ID: 10512506 [No Abstract] [Full Text] [Related]
19. Meta-analysis of the safety of 5-HT3 antagonists with dexamethasone or droperidol for prevention of PONV. Leslie JB; Gan TJ Ann Pharmacother; 2006 May; 40(5):856-72. PubMed ID: 16670360 [TBL] [Abstract][Full Text] [Related]
20. Antiemetic-related dystonic reaction unmasked by removal of a scopolamine transdermal patch. Roberge RJ J Emerg Med; 2006 Apr; 30(3):299-302. PubMed ID: 16677982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]